Covered recipient · General Payments record
JEFFREY CRAGUN
General Payments · PY2018–2021
$20,576.33
- Reported across 127 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $184.22 | 12 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.72 | 9 |
| Daiichi Sankyo Inc. | $31.11 | 2 |
| TherapeuticsMD, Inc. | $11.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.02 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295921 | CMS |
| AbbVie Inc. | $6.73 | 02/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295923 | CMS |
| AbbVie Inc. | $29.93 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295925 | CMS |
| AbbVie Inc. | $14.69 | 03/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295927 | CMS |
| AbbVie Inc. | $7.58 | 04/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295929 | CMS |
| AbbVie Inc. | $28.47 | 04/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295931 | CMS |
| AbbVie Inc. | $6.94 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295933 | CMS |
| AbbVie Inc. | $6.69 | 05/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295935 | CMS |
| AbbVie Inc. | $22.67 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794295937 | CMS |
| Daiichi Sankyo Inc. | $11.74 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836276515 | CMS |
| Daiichi Sankyo Inc. | $19.37 | 04/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836286187 | CMS |
| TherapeuticsMD, Inc. | $11.39 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844914019 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.